NCT02419547View on ClinicalTrials.gov

Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 26, 2015

Study Completion Date

April 26, 2015

Conditions
Ventricular Tachycardia
Interventions
DRUG

Versed

Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia

DRUG

Fentanyl

Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia

DRUG

Propofol

Phase 2: Standard induction of GETA with intravenous agent then programed stimulation to induce ventricular tachycardia

DRUG

Sevoflurane

Phase 3: Standard induction of GETA with inhalent agent then programed stimulation to induce ventricular tachycardia

Trial Locations (1)

02115

Brigahm and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT02419547 - Inducibility and Stability of Ventricular Tachycardia Inpatients Undergoing VT Ablation Under General Anesthesia | Biotech Hunter | Biotech Hunter